default image

Urologie

Information and services of the department

  • Number of inpatient cases: 745

Services search (in the department)


Illness Number of cases
Malignant neoplasm of prostate (C61) 158
Hyperplasia of prostate (N40) 100
Calculus of kidney and ureter - Calculus of kidney (N20.0) 74
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 55
Obstructive and reflux uropathy - Crossing vessel and stricture of ureter without hydronephrosis (N13.5) 51
Calculus of kidney and ureter - Calculus of ureter (N20.1) 46
Urethral stricture (N35.0) 29
Malignant neoplasm of bladder - Malignant neoplasm of trigone of bladder (C67.0) 16
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) 15
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1) 13
Treatment Number
Other procedure on the kidney, ureter, bladder or urethra (8-139.x) 603
Injection or administration of medicines into the urinary bladder (8-132.3) 280
Treatment by injecting a medicine into an organ or tissue, or removal of excess fluid (effusion) e.g. from the joints (8-020.x) 162
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) 142
Insertion, exchange or removal of a ureteral stent (8-137.10) 104
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 99
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) 78
Examination of the ureter by endoscopy (1-665) 67
Surgical incision into a kidney, insertion of a tube to drain urine from the kidney, removal of a stone (calculus) through a surgical incision, dilatation of the renal pelvis or removal of a stone by endoscopy (5-550.31) 57
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11) 57

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Number Group
0 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
0 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
0 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Sandra Kröning

Medizincontrolling

Phone: 0451 -2007-497
Mail: ed.tiehdnuseg-soileh@gnineork.ardnas

Dr. med. Söhnke Boye

Ärztlicher Direktor

Phone: 0451 -20070-
Mail: ed.tiehdnuseg-soileh@eyob.eknheos

Dr. med. Söhnke Boye

Ärztlicher Direktor, Facharzt für Anästhesie

Phone: 0451 -20070-
Mail: ed.tiehdnuseg-soileh@eyob.eknheos